Hui-Ming Lin 29th Lorne Cancer Conference 2017

Abstracts this author is presenting:

• Phase 2 study of circulating microRNA biomarkers in metastatic prostate cancer — Poster Session II
• FAK inhibitor VS-6063 enhances docetaxel chemotherapy efficacy in prostate cancer — Poster Session II